China Pharma Holdings (00512.HK): Expected net profit of HK$1.2 billion to HK$1.25 billion for fiscal year 2025

2026-03-24 06:29:21

Gelonghui, March 20 — Yuanda Pharmaceutical (00512.HK) announced that it expects the profit attributable to owners of the company for the year ending December 31, 2025, to be between HKD 1.2 billion and HKD 1.25 billion, compared to approximately HKD 2.47 billion for the audited corresponding period in 2024. It also expects the adjusted operating profit attributable to owners of the company for the year ending December 31, 2025, to be between HKD 1.45 billion and HKD 1.5 billion, compared to approximately HKD 1.76 billion for the audited corresponding period in 2024.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.